Skip to main content
Home
  • FULL MENU FULL MENU
    • Federal Practitioner Home
    • Digital Edition/App
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    News

    One VA Cancer Pathway to Rule Them All?

    Author:
    Randy Dotinga
    Publish date: November 28, 2023

    The US Department of Veterans Affairs (VA) has developed clinical pathways to guide its clinicians through cancer...

    • Read More

    Latest News

    Redispensing unused cancer meds cuts waste, saves money

    Author:
    Megan Brooks
    Publish date: November 21, 2023

    Researchers compared the reduction in drug waste and cost savings from redispensing oral anticancer drugs versus the standard practice of...

    • Read More

    MD IQ

    Quiz: Sarcomatoid Renal Cell Carcinoma

    Latest News

    GLP-1 RAs tied to suboptimal bowel prep, repeat colonoscopy

    Author:
    Marilynn Larkin
    Publish date: November 21, 2023

    “Specifically, for every 14 patients treated with GLP-1 RAs, one patient would require a repeat colonoscopy due to suboptimal preparation.”

    • Read More

    Latest News

    Surgery is falling out of favor in rectal cancer

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: November 21, 2023

    “This case series shows that rectal cancer is increasingly being managed medically,” the authors said.

    • Read More

    News

    Breast milk liquid biopsy under study for early-stage breast cancer detection

    Author:
    Carla Nieto MartÍnez
    Publish date: November 20, 2023

    Just like taking a small blood sample from newborns in a heel-prick test to rule out metabolic diseases, milk samples could be taken from women...

    • Read More

    News

    Can a Mediterranean diet reduce breast cancer recurrence?

    Author:
    Megan Brooks
    Publish date: November 17, 2023

    A growing body of evidence suggests that a better dietary quality may improve survival among patients with breast cancer, but whether diet impacts...

    • Read More

    News

    FDA OKs capivasertib for certain advanced breast cancers

    Author:
    Sharon Worcester, MA
    Publish date: November 17, 2023

    The FDA also approved a companion diagnostic device, the FoundationOne CDx assay, to identify patients who are eligible for treatment with...

    • Read More

    News

    FDA panel voices concerns over 2 lymphoma accelerated approvals

    Author:
    Kerry Dooley Young
    Publish date: November 17, 2023

    FDA’s ODAC committee pressed for resolution on whether 2 lymphoma drugs, long on the U.S. market, actually deliver significant benefits to...

    • Read More

    News

    Unexplained collapse unveils rare blood disorder

    Author:
    Deepa Varma
    Publish date: November 17, 2023

    Acquired TTP often appears to arise in connection with either an immune trigger, such as a viral infection, or immune dysregulation associated...

    • Read More

    News

    False-positive mammography results and risk for cancer death

    Author:
    Sharon Worcester
    Publish date: November 16, 2023

    The analysis provides clues about which patients with false-positive mammography results will go on to develop breast cancer and “can be used to...

    • Read More

    News

    People with diabetes have a higher risk of colon cancer: Study

    Author:
    Lisa O’Mary
    Publish date: November 16, 2023

    The authors concluded that increased referrals for colonoscopies among people with diabetes, particularly among those newly diagnosed, could...

    • Read More

    Article

    Updated: Federal Practitioner Submission Guidelines

    Publish date: September 12, 2016

    Federal Practitioner welcomes submission of manuscripts on subjects pertinent to physicians, clinical pharmacists, physician...

    • Read More

    News

    Study confirms small blood cancer risk from CT scans

    Author:
    Megan Brooks
    Publish date: November 15, 2023

    New research suggests that radiation exposure from CT scans heightens the risk of blood cancer in people under age 22.

    • Read More

    Latest News

    Chronic diarrhea management: Be wary of false diarrhea

    Author:
    Vincent Richeux
    Publish date: November 15, 2023

    After ruling out false diarrhea, clinicians should be vigilant for warning signs.

    • Read More

    MD IQ

    Quiz: Skin cancer in US military

    Latest News

    Jury still out on whether green tea lowers colon cancer risk

    Author:
    Damian McNamara, MA
    Publish date: November 15, 2023

    Combining random trials so far shows no advantage from green tea. But there may still be a benefit.

    • Read More

    Opinion

    Can vitamin and mineral supplementation prevent cancer or cardiovascular disease?

    Author:
    Linda Girgis, MD
    Publish date: November 14, 2023

    Listen to your patients about vitamin and mineral supplements, answer their questions, and tell them the facts.

    • Read More

    Conference Coverage

    FDA’s Project Optimus aims to transform early cancer research

    Author:
    Randy Dotinga
    Publish date: November 14, 2023

    Q & A with an expert on how the FDA’s Project Optimus targets toxicity and how it could spell the end of traditional dose-escalation trials....

    • Read More

    MD IQ

    Quiz: Prognostic factors of bladder cancer

    Latest News

    Actinic keratoses may predict skin cancers in older adults

    Author:
    Heidi Splete
    Publish date: November 14, 2023

    AKs have been associated with a small risk for cutaneous SCC, but associations with risk for other skin cancers have not been well studied.

    • Read More

    Latest News

    Incipient ulceration may affect prognosis in primary melanoma

    Author:
    Doug Brunk
    Publish date: November 14, 2023

    “Future editions of the AJCC staging system should consider acknowledging this interpretive challenge and provide guidance on how primary...

    • Read More

    Conference Recap

    Highlights in Early Breast Cancer From ESMO 2023

    Author:
    Lisa A. Carey, MD
    Publish date: November 13, 2023

    Highlights in early breast cancer from ESMO 2023 include 5-year results from KEYNOTE-522 in TNBC, pCR benefits in ER+/HER2-, and a genomic risk...

    • Read More

    News

    FDA approves first tx for rare, deadly clotting disorder

    Author:
    Sharon Worcester, MA
    Publish date: November 13, 2023

    First drug to treat TTP. a rare, lethal blood clotting disorder, has been greenlighted by the FDA.

    • Read More

    Clinical Topics

    • COVID can mimic prostate cancer symptoms
      Publish date: March 21, 2023
    • Biden to end COVID emergencies in May
      Publish date: January 31, 2023
    • Study of beliefs about what causes cancer sparks debate
      Publish date: January 3, 2023
    • FDA approves first gene therapy for hemophilia B
      Publish date: November 22, 2022
    • Tips on Better Patients Communication
      Publish date: October 26, 2022
    more

    Education Center

    • Federal Health Care Data Trends 2021
      Publish date: July 29, 2021
    • 2020 Cancer Data Trends
      Publish date: September 11, 2020
    • Abstracts Presented at the 2020 AVAHO Annual Meeting (Digital Edition)
    • Abstracts Presented at the 2019 AVAHO Annual Meeting (Digital Edition)
    • Abstracts Presented at the 2018 AVAHO Annual Meeting (Digital Edition)
    more

    Featured Multimedia

    • Can a biodegradable brain implant deliver lifesaving cancer meds?
      Publish date: July 11, 2023
    • Freefall: How Skydiving Is Like Cancer Surgery
      Publish date: June 1, 2021
    • A Pivotal Moment in Cancer Surgery, Captured on Film
      Publish date: April 30, 2021
    Visit our multimedia library

    Digital Edition

    • Cancer Data Trends 2023
      Publish date: July 5, 2023
    • Cancer Data Trends 2022
      Publish date: March 30, 2022
    • AVAHO 2021 Meeting Posters and Abstracts
      Publish date: September 22, 2021
    • Advances in Hematology and Oncology
      Publish date: September 3, 2021
    • Advances in Hematology and Oncology
      Publish date: May 20, 2021
    more

    Conference Coverage

    • FDA’s Project Optimus aims to transform early cancer research
      Publish date: November 14, 2023
    • In MI with anemia, results may favor liberal transfusion: MINT
      Publish date: November 13, 2023
    • Particulate pollution increases the risk for breast cancer
      Publish date: November 9, 2023
    • T-cell cancers: CAR T therapy to the rescue?
      Publish date: November 9, 2023
    • Gut microbiome variations may be predictive of precancerous colonic lesions, CRC
      Publish date: November 2, 2023
    • AI flagged skin cancer with near-perfect accuracy, in UK study
      Publish date: November 1, 2023
    • Neoadjuvant, adjuvant, or both? The debate in NSCLC rages on
      Publish date: October 27, 2023
    • Two multitarget stool tests show promise for CRC screening: Studies
      Publish date: October 27, 2023
    • Rare lymphomas: Desperately seeking new txs
      Publish date: October 27, 2023
    • ‘We finally made it’: Amivantamab comes of age in NSCLC
      Publish date: October 26, 2023
    more

    Sarcomatoid Renal Cell Carcinoma

    Question 1 of 5

    What is the median age of presentation for sarcomatoid renal cell carcinoma (sRCC)?

    Childhood (younger than 10 years)

    Adolescence (10-19 years)

    Early adulthood (30-50 years)

    Late adulthood (50 years or older)

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    FULL MENU FULL MENU Presented by
    • FULL MENU FULL MENU

      More

      • Federal Practitioner Home
      • Digital Edition/App

    More

    • Federal Practitioner Home
    • Digital Edition/App